國立虎尾科技大學 |

Pharmacotherapy for Liver Cirrhosis and Its Complications

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Pharmacotherapy for Liver Cirrhosis and Its Complications/ edited by Xingshun Qi, Yongping Yang.
其他作者:	Yang, Yongping.
面頁冊數:	XII, 240 p. 20 illus., 16 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Internal Medicine. -
電子資源:	https://doi.org/10.1007/978-981-19-2615-0
ISBN:	9789811926150

Pharmacotherapy for Liver Cirrhosis and Its Complications
Pharmacotherapy for Liver Cirrhosis and Its Complications[electronic resource] /edited by Xingshun Qi, Yongping Yang. - 1st ed. 2022. - XII, 240 p. 20 illus., 16 illus. in color.online resource.

Anti-HBV drugs in liver cirrhosis -- Anti-HCV drugs in liver cirrhosis -- Anticoagulants in liver cirrhosis -- Antibiotics in liver cirrhosis -- Silymarin in liver cirrhosis -- Ursodeoxycholic acid in liver cirrhosis -- Emricasan in liver cirrhosis -- Non-selective beta blockers in liver cirrhosis -- Somatostatin and octreotide in liver cirrhosis -- Terlipressin in liver cirrhosis -- Diuretics in liver cirrhosis -- Statins in liver cirrhosis -- L-Ornithine L-Aspartate in liver cirrhosis -- Lactulose in liver cirrhosis.

This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.

ISBN: 9789811926150

Standard No.: 10.1007/978-981-19-2615-0doiSubjects--Topical Terms:

668583
Internal Medicine.

LC Class. No.: RC1-1245

Dewey Class. No.: 616

Pharmacotherapy for Liver Cirrhosis and Its Complications
LDR:02645nam a22003975i 4500 001 1089049
003 DE-He213
005 20220726125453.0
007 cr nn 008mamaa
008 221228s2022 si | s |||| 0|eng d
020 $a 9789811926150 $9 978-981-19-2615-0
024 7 $a 10.1007/978-981-19-2615-0 $2 doi
035 $a 978-981-19-2615-0
050 4 $a RC1-1245
072 7 $a MJ $2 bicssc
072 7 $a MED045000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 616 $2 23
245 1 0 $a Pharmacotherapy for Liver Cirrhosis and Its Complications $h [electronic resource] / $c edited by Xingshun Qi, Yongping Yang.
250 $a 1st ed. 2022.
264 1 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a XII, 240 p. 20 illus., 16 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Anti-HBV drugs in liver cirrhosis -- Anti-HCV drugs in liver cirrhosis -- Anticoagulants in liver cirrhosis -- Antibiotics in liver cirrhosis -- Silymarin in liver cirrhosis -- Ursodeoxycholic acid in liver cirrhosis -- Emricasan in liver cirrhosis -- Non-selective beta blockers in liver cirrhosis -- Somatostatin and octreotide in liver cirrhosis -- Terlipressin in liver cirrhosis -- Diuretics in liver cirrhosis -- Statins in liver cirrhosis -- L-Ornithine L-Aspartate in liver cirrhosis -- Lactulose in liver cirrhosis.
520 $a This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.
650 1 4 $a Internal Medicine. $3 668583
650 0 $a Internal medicine. $3 644638
700 1 $a Yang, Yongping. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1396287
700 1 $a Qi, Xingshun. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1312970
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811926143
776 0 8 $i Printed edition: $z 9789811926167
776 0 8 $i Printed edition: $z 9789811926174
856 4 0 $u https://doi.org/10.1007/978-981-19-2615-0
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)